Convergence of Wnt, growth factor, and heterotrimeric G protein signals on the guanine nucleotide exchange factor

Nicolas Aznar1, Jason Ear2, Ying Dunkel2

  • 1Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA. nicolas.aznar@inserm.fr prghosh@ucsd.edu.

Science Signaling
|March 1, 2018
PubMed

Insights

Daple protein links Wnt/Frizzled, receptor tyrosine kinase (RTK), and G protein pathways. RTK phosphorylation of Daple enhances G protein activity and Wnt signaling, promoting cancer progression despite Daple

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Biology

Background:

  • Cellular processes like proliferation and differentiation are regulated by signaling cascades.
  • Dysregulation of Wnt, receptor tyrosine kinase (RTK), and G protein-coupled receptor (GPCR) pathways contributes to cancer.
  • Daple protein interacts with Wnt/Frizzled (FZD) and G proteins, influencing Wnt signaling.

Purpose of the Study:

  • To investigate Daple's role as a convergence point for Wnt, RTK, and G protein signaling cascades.
  • To elucidate how Daple's interaction with these pathways affects cancer progression.
  • To understand the dual role of Daple in normal tissue and colorectal tumors.

Main Methods:

  • Identified Daple as a substrate for multiple RTKs and non-RTKs.
  • Analyzed Daple's phosphorylation near the Dishevelled (Dvl)-binding motif.
  • Assessed the impact of phosphorylation on Daple/Dvl complex formation and Gαi activation.
  • Studied the potentiation of β-catenin-independent Wnt signals and epithelial-mesenchymal transition (EMT).

Main Results:

  • RTK-mediated phosphorylation of Daple disrupts the Daple/Dvl complex.
  • Phosphorylation enhances Daple's binding to and activation of Gαi, potentiating Wnt signals.
  • This mechanism stimulates EMT, similar to Wnt5a/FZD7 signaling.
  • While Daple is a tumor suppressor in healthy colon, its increased abundance with EGFR in colorectal tumors correlates with poor prognosis.

Conclusions:

  • Daple acts as a crucial cross-talk hub integrating RTK, G protein, and Wnt/FZD pathways.
  • Growth factor-activated RTKs can hijack Daple-mediated signaling to promote tumor progression.
  • The findings reveal a novel paradigm for pathway interaction in cancer development.

Related Concept Videos

Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
580
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.9K
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
492
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
340
Transcription Elongation Factors02:35

Transcription Elongation Factors

Transcription elongation is a dynamic process that alters depending upon the sequence heterogeneity of the DNA being transcribed. Hence, it is not surprising that the elongation complex's composition also varies along the way while transcribing a gene.
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
14.1K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
4.0K